Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Effect on Lipoprotein Metabolism and Liver Fat in Type 2 Diabetes
NCT02765399Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Feb 2015
- Primary completion
- Feb 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Helsinki University Hospital. Started Feb 2015; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02765399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02765399.